mesalamine has been researched along with Ventricular Dysfunction, Left in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Ye, J | 1 |
| Zhu, J | 1 |
| Chen, W | 1 |
| Sun, Y | 1 |
1 other study available for mesalamine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Myocarditis due to mesalamine treatment in a patient with Crohn's disease in China.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; China; Crohn Disease; Echocardiography; Electrocardi | 2012 |